Status:
COMPLETED
Haemodialysis Salt Reduction Study
Lead Sponsor:
St George's, University of London
Conditions:
Kidney Failure, Chronic
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
High blood pressure (hypertension) affects up to 80% of all patients receiving haemodialysis for chronic kidney disease (CKD). High blood pressure is a major cause cardiovascular disease (i.e. strokes...
Detailed Description
High blood pressure (BP) is a major independent risk factor for cardiovascular mortality in individuals on haemodialysis, and yet BP is extremely poorly controlled in this population. Excessive dieta...
Eligibility Criteria
Inclusion
- Haemodialysis/haemodiafiltration for ESRF for \>3 months
- Clinically stable
Exclusion
- Significant intercurrent illness
- Systolic BP \>240 mmHg/diastolic BP \>120 mmHg at enrollment
- Unstable blood pressure whilst on HD
- Sodium profiled haemodialysis/HDF
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00141609
Start Date
April 1 2004
End Date
October 1 2006
Last Update
May 14 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blood Pressure Unit, Cardiac & Vascular Sciences, SGUL
London, United Kingdom, SW17 0RE